Evidence map›Paper›PMID 36132927›Full record

ArticleNanoscale advances2020

Amyloid hybrid membranes for bacterial & genetic material removal from water and their anti-biofouling properties.

Archana Palika, Akram Rahimi, Sreenath Bolisetty, Stephan Handschin, Peter Fischer, Raffaele Mezzenga

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. DisruptingFrontiers in cellular and infection microbiology · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Archana PalikaETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.
Akram RahimiETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.
Sreenath BolisettyETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.ORCID https://orcid.org/0000-0002-1040-8945
Stephan HandschinETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.
Peter FischerETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.ORCID https://orcid.org/0000-0002-2992-5037
Raffaele MezzengaETH Zurich, Department of Health Sciences and Technology Schmelzbergstrasse 9 8092 Zurich Switzerland.ORCID https://orcid.org/0000-0002-5739-2610
ETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water scarcity and contamination by biological pollutants are global challenges that significantly affect public health. Reverse osmosis, nanofiltration and ultrafiltration technologies are very effective for the elimination of pathogens and most contaminants but associated with considerable capital and operating costs, high energy consumption and the use of chlorinated chemicals to suppress membrane fouling. Additionally, the pressure needed by these techniques may disrupt the pathogenic microbial cell membranes, causing the release of genetic material (fragments of DNA, RNA and plasmids) into the water. Here, we introduce the simultaneous removal of both bacteria and associated genetic material using amyloid hybrid membranes,

Identifiers

PMID36132927
PMCPMC9419293
OpenAlexW3084805905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.